It is conceivable that NK cell killing of tumor cells could provide antigens subsequently taken up, processed, and cross-presented by DCs; at the same time, activation of NK cells is associated to the secretion of cytokines, such as TNF or IFN-γ, potentially able to help cross-priming of specific CTLs (Figure 2). The gene discussed is IFNG; the disease is neoplasm.